The model recapitulates advanced-stage empyema in humans, levels of intrapleural biomarkers of inflammation and PAI-1, showing increasingly severe pleural injury and pleural thickening in combination with resistance to bolus injection fibrinolytic therapy with high doses of sctPA and scuPA. The gene discussed is SERPINE1; the disease is empyema.